|
Our Altascientists are hard at work, whether it’s on your drug development projects, or producing insightful scientific resources to share their knowledge with you. Catch up on what you may have missed, or revisit some highlights from the last three months.
|
|
|
A Message from Our CEO to You
Each quarter, Chris Perkin reflects on the past, present, and future of Altasciences. Read what Chris has to say.
Blog: Up Close and Personal With…
Get to know Dr. Simone Iwabe, DVM, PhD, DACVO, Senior Veterinary Ophthalmologist at Altasciences.
Altasciences was Named the Best Pharmaceutical & Biotechnology Research Organization of 2021 by Global Health & Pharma News
Podcast: The Canadian Business Quarterly Interviews CEO Chris Perkin
Listen as Chris discusses the integration model at the heart of Altasciences’ DNA and our problem-solving approach to the drug development journey.
Blog: Current Trends in Drug Development
The drug development landscape has evolved from an earlier emphasis on blockbuster drugs to a more inclusive, patient-centered paradigm. In this blog, discover how these trends have revitalized drug development, opened new markets, made cutting-edge treatments accessible to more patients, and enabled the inclusion of a more diversified range of study participants.
|
|
|
News: Altasciences Acquires Sinclair Research and Continues to Expand Preclinical Platform
Read all about it! On January 4th, we announced the acquisition of a preclinical site in Columbia, MO, complementing our existing preclinical locations in Seattle, WA, and Scranton, PA. This new site will facilitate even greater access to Altasciences’ preclinical services across the U.S.
News: Dr. Wendell P. Davis Joins Altasciences as Vice President, Pathology
Read all about it! Dr. Davis has extensive experience in toxicologic pathology from both the biotechnology and CRO sectors. He is a proven leader with a passion for building pathology capabilities and mentoring pathologists, researchers, and laboratory scientists.
On-Demand Webinar: Case Studies — Adversity Level Determination in Nonclinical Toxicity
Watch as Julie Forget, DESS Tox, DABT, Director of Safety Assessment, shares her expertise in data interpretation and her perspective on how to think critically when assessing toxicity on selected study endpoints.
Quiz: Test Your Preclinical Toxicology Knowledge
Take our short 7-question quiz to discover how much you know (or don’t know) about toxicology.
|
|
|
News: Altasciences Chosen by Virpax Pharmaceuticals, Inc. to Conduct First-in-Human Study of Epoladerm™ for Chronic Pain Associated with Osteoarthritis of the Knee
Read all about it! The treatment, which is supplied in a pre-filled device for administration as a topical spray, will be studied at Altasciences’ clinical pharmacology unit in Montreal, Canada, with the goal of providing robust data in support of the 505(b)(2) FDA approval pathway.
On-Demand Webinar: A Hop Across the Pond
Watch as Dr. Beatrice Setnik, Chief Scientific Officer, and Ingrid Holmes, Vice President of Global Clinical Operations, present the key advantages of conducting early phase clinical trials in North America.
|
|
|
Scientific Journal: The Altascientist Issue No. 22 — Nanomilling for Better Solubility and Improved Bioavailability
Explore how to overcome solubility challenges as well as the workings and benefits of nanomilling. Includes a case study! Issue No. 22 is also available as an audiobook.
E-Book: Benefits of Liquid-Filled Capsules in Pharmaceutical Development
Everything you need to know about LFCs: discover how they work, their logistical advantages, applications for APIs, customized options, and marketing opportunities.
|
|
|
On-Demand Webinar: Development of a Cell-Based Assay for Dual Purposes
Watch as we share our process for developing cell-based assays to support drug potency and immunogenicity characterization. In this webinar, we discuss all critical evaluations, and highlight time and cost savings when developing an assay for both applications. Presented by Dr. Danielle Salha, PhD, Senior Director, Immunochemistry & Immunology, Ligand Binding Assays.
|
|
|
On-Demand Webinar: The Path Forward — Altasciences’ Approach to Project Management
Watch as Lauren Szczurowski, Vice President of Scientific Project Management, and Melanie Barth, Associate Director of Scientific Project Management, discuss how our hybrid approach to project management can benefit your drug development program.
Quick Chat: Leading Your Clinical Trial Applications with Confidence
Listen to Roland Jbeily, Manager of Regulatory Affairs, as he shares his insight on helping sponsors with their CTA submissions to Health Canada.
|
|
|